(Q33368612)

English

High-dose busulfan and thiotepa followed by autologous stem cell transplantation (ASCT) in previously irradiated medulloblastoma patients: high toxicity and lack of efficacy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

High-dose busulfan and thiotepa followed by autologous stem cell transplantation (ASCT) in previously irradiated medulloblastoma patients: high toxicity and lack of efficacy (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

medulloblastoma

0 references

author name string

Valteau-Couanet D

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Fillipini B

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Benhamou E

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Grill J

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Kalifa C

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Couanet D

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Habrand JL

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Hartmann O

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

1 December 2005

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

36

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

939-945

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

The treatment and long-term prognosis of children with intracranial tumors: a study of 610 cases, 1950-1981.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705162

21 January 2018

Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705162

21 January 2018

Effects of medulloblastoma resections on outcome in children: a report from the Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705162

21 January 2018

Radiotherapy for medulloblastoma in children: a perspective on current international clinical research efforts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705162

21 January 2018

Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705162

21 January 2018

Chemotherapy of recurrent medulloblastoma with combined procarbazine, CCNU, and vincristine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705162

21 January 2018

The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705162

21 January 2018

Survival and neurologic outcome of infants with medulloblastoma treated with surgery and MOPP chemotherapy. A preliminary report.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705162

21 January 2018

Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705162

21 January 2018

Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705162

21 January 2018

Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705162

21 January 2018

Brain tumors in the very young child. Postoperative chemotherapy in combined-modality treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705162

21 January 2018

Postoperative chemotherapy without radiation in young children with malignant non-astrocytic brain tumours. A report from the Australia and New Zealand Childhood Cancer Study Group (ANZCCSG).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705162

21 January 2018

Will high dose chemotherapy followed by autologous bone marrow transplantation supplant cranio-spinal irradiation in young children treated for medulloblastoma?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705162

21 January 2018

High dose chemotherapy with autologous stem cell rescue for patients with medulloblastoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705162

21 January 2018

High-dose chemotherapy with autologous stem cell rescue for malignant brain tumors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705162

21 January 2018

Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer Group.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705162

21 January 2018

High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705162

21 January 2018

High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705162

21 January 2018

High-dose carmustine, thiotepa and etoposide followed by autologous bone marrow rescue for the treatment of high risk central nervous system tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705162

21 January 2018

Surveillance scanning of children with medulloblastoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705162

21 January 2018

Possible benefits of high-dose chemotherapy and autologous stem cell transplantation for adults with recurrent medulloblastoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705162

21 January 2018

Convulsions due to high-dose busulphan

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705162

21 January 2018

Antiinfective prophylaxis with ceftazidime and teicoplanin in children undergoing high-dose chemotherapy and bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705162

21 January 2018

Criteria and definitions for response and relapse in children with brain tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705162

21 January 2018

Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705162

21 January 2018

Medulloblastoma: freedom from relapse longer than 8 years--a therapeutic cure?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705162

21 January 2018

A phase II evaluation of thiotepa in pediatric central nervous system malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705162

21 January 2018

Busulphan is active against neuroblastoma and medulloblastoma xenografts in athymic mice at clinically achievable plasma drug concentrations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705162

21 January 2018

High dose chemotherapy for childhood ependymona

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705162

21 January 2018

Radiotherapy followed by high dose busulfan and thiotepa: a prospective assessment of high dose chemotherapy in children with diffuse pontine gliomas.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705162

21 January 2018

The cellular basis of long-term marrow injury after irradiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705162

21 January 2018

Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705162

21 January 2018

Treatment of patients with pineoblastoma with high dose cyclophosphamide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705162

21 January 2018

High-dose multi-agent chemotherapy followed by bone marrow 'rescue' for malignant astrocytomas of childhood and adolescence.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705162

21 January 2018

High-dose busulfan and cyclophosphamide with autologous bone marrow transplantation support in advanced malignancies in children: a phase II study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705162

21 January 2018

Prophylaxis with defibrotide prevents veno-occlusive disease in stem cell transplantation after gemtuzumab ozogamicin exposure.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705162

21 January 2018

Regimen-related toxicity in patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705162

7 January 2021

based on heuristic

inferred from DOI database lookup

Late effects on human bone marrow after extended field radiotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705162

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose melphalan with autologous stem-cell rescue in metastatic rhabdomyosarcoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705162

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705162

7 January 2021

based on heuristic

inferred from DOI database lookup

Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705162

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1705162

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33368612&oldid=2195291753"